Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01062191 · ClinicalTrials.gov registry record · NA
Altrazeal Range of Motion Study Comparing With Typical Carboxymethyl
A NA study, sponsored by ULURU.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01062191: Clinical Trial NA study, sponsored by ULURU.
NCT01062191 is a NA study that was terminated before completion, run by ULURU. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01062191, a NA study, was terminated before completion, sponsored by ULURU.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the difference in joint range of motion of a new flexible hydrogel nanoparticle wound dressing compared to typical sodium carboxymethylcellulose dressing Aquacel AG for treatment of partial thickness burns.
Interventions
- DEVICE Aquacel AG, typical carboxymethylcellulose dressing
- DEVICE Altrazeal Flexible Hydrogel Nanoparticle Wound Dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2007-05 |
| Est. Completion | 2008-10 |
| Phase | NA |
Why NCT01062191 stopped before completion
NCT01062191 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Aquacel AG, typical carboxymethylcellulose dressing is the first listed.
NCT01062191 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01062191 about?
NCT01062191 is a clinical study titled "Altrazeal Range of Motion Study Comparing With Typical Carboxymethyl". The objective of this study is to evaluate the difference in joint range of motion of a new flexible hydrogel nanoparticle wound dressing compared to typical sodium carboxymethylcellulose dressing Aquacel AG for treatment of partial thickness burns.
What is the current status of trial NCT01062191?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2007-05. Estimated completion is 2008-10.
What interventions are being tested in trial NCT01062191?
The interventions under investigation include: Aquacel AG, typical carboxymethylcellulose dressing (DEVICE), Altrazeal Flexible Hydrogel Nanoparticle Wound Dressing (DEVICE).
Who is sponsoring clinical trial NCT01062191?
This trial is sponsored by ULURU, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01062191's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia